Shopping Cart
Remove All
Your shopping cart is currently empty
Nifedipine-13C8 is a deuterium-labeled form of Nifedipine. Nifedipine (BAY-a-1040) acts as an effective calcium channel blocker, frequently utilized in studies related to myocardial dysfunction.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Nifedipine-13C8 is a deuterium-labeled form of Nifedipine. Nifedipine (BAY-a-1040) acts as an effective calcium channel blocker, frequently utilized in studies related to myocardial dysfunction. |
| In vivo | At the conclusion of the fourth week, there is a significant increase (P < 0.05) in the BL dimensions (BLi and BLk), MD dimensions (MDk), and vertical dimensions (VHi and VHk) in rats treated with Nifedipine (BAY-a-1040) (50 mg/kg) and CsA. |
| Molecular Weight | 354.28 |
| Formula | C17H18N2O6 |
| Cas No. | 1173023-46-5 |
| Smiles | CO[13C]([13C]1=[13C]([13CH3])N[13C]([13CH3])=[13C]([13C](OC)=O)C1C2=C(C=CC=C2)[N+]([O-])=O)=O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.